drugset / Trial / NCT00021346

Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors

NCT00021346 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining carboplatin and gemcitabine in treating patients who have advanced solid tumors.

Timeline

Start
1997-11
Primary completion
2001-07
Completion
2002-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — Intravenous
Subject Gemcitabine Small molecule — Intravenous